IL1R2 blockade significantly reduces the BCSCs population, inhibits macrophage recruitment and M2 polarization, and prevents CD8+ T-cell exhaustion, collectively contributing to tumor suppression [244]. The gene discussed is IL1R2; the disease is neoplasm.